X4 Pharmaceuticals Inc XFOR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/24 EDT
0.90quote price arrow down-0.0002 (-0.0222%)
Volume
27,007
Close
0.9002UNCH (UNCH)
Volume
1,204,293
52 week range
0.57 - 2.58
Loading...
  • Open0.90
  • Day High0.9198
  • Day Low0.881
  • Prev Close0.9284
  • 52 Week High2.58
  • 52 Week High Date06/13/23
  • 52 Week Low0.57
  • 52 Week Low Date12/12/23

Key Stats

  • Market Cap151.178M
  • Shares Out167.94M
  • 10 Day Average Volume3.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.38
  • YTD % Change7.36

KEY STATS

  • Open0.90
  • Day High0.9198
  • Day Low0.881
  • Prev Close0.9284
  • 52 Week High2.58
  • 52 Week High Date06/13/23
  • 52 Week Low0.57
  • 52 Week Low Date12/12/23
  • Market Cap151.178M
  • Shares Out167.94M
  • 10 Day Average Volume3.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.38
  • YTD % Change7.36

RATIOS/PROFITABILITY

  • EPS (TTM)-0.70
  • P/E (TTM)-1.29
  • Fwd P/E (NTM)-1.83
  • EBITDA (TTM)-115.153M
  • ROE (TTM)-489.12%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,071.03%
  • Debt To Equity (MRQ)5,291.89%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On X4 Pharmaceuticals Inc

 

Profile

MORE
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4, that is being developed as an oral, once-daily therapy. It has developed...
Michael Wyzga
Non-Executive Independent Chairman of the Board
Paula Ragan Ph.D.
President, Chief Executive Officer, Secretary, Director
Mary Dibiase Ph.D.
Chief Operating Officer
Adam Mostafa
Chief Financial Officer, Treasurer, Corporate Secretary
Address
61 NORTH BEACON STREET, 4TH FLOOR
Boston, MA
02134
United States

Top Peers

SYMBOLLASTCHG%CHG
GLSI
Greenwich Lifesciences Inc
13.08UNCHUNCH
ELEV
Elevation Oncology Inc
3.74UNCHUNCH
PROK
ProKidney Corp
3.88UNCHUNCH
DRTS
Alpha Tau Medical Ltd
2.71UNCHUNCH
GOSS
Gossamer Bio Inc
0.6833UNCHUNCH